How does the prognosis differ for patients with relapsed versus refractory diffuse large B-cell lymphoma?

The prognosis for patients with relapsed versus refractory DLBCL differs significantly, with refractory status generally associated with poorer outcomes. Direct evidence correlates clinical, metabolic, and genetic factors with these prognostic differences, guiding personalized treatment strategies.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23769127
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How does the prognosis differ for patients with relapsed versus refractory diffuse large B-cell lymphoma?

Tripdatabase
1 links
Zenodo (CERN European Organization for Nuclear Research)
Lymphoma Diagnosis and Treatment
article

How does the prognosis differ for patients with relapsed versus refractory diffuse large B-cell lymphoma?

Tripdatabase
article en

Abstract

The prognosis for patients with relapsed versus refractory DLBCL differs significantly, with refractory status generally associated with poorer outcomes. Direct evidence correlates clinical, metabolic, and genetic factors with these prognostic differences, guiding personalized treatment strategies.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 13%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
How does the prognosis differ for patients with relapsed versus refractory diffuse large B-cell lymphoma? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS